We spoke with the firm’s founder Miquel Bonachera at our recent Probiota Asia Summit in Singapore.
In this video, he explains the reasons for investing in the strain, which was discovered during a collaboration between Clinical Nutrition Sdn Bhd and University Sains Malaysia in 2014.
In addition to discussing the future research priorities and the latest understanding around the strain's mechanism of action, he also evaluates the business opportunities for new product development in the cognitive health space across a raft of life stages.
Watch the video for more.
